IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$2.17
+0.09 (+4.33%)
As of Mar 25, 4:46 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +552.5% upside
Low Target $9.87
Average Target $14.16
High Target $18.59
Current Price $2.17
Current
$2.17
Target
$14.16
$9.87 $14.16 avg $18.59
Scenario Analysis
Bear Case
$9.87
354.8%
Low target
Base Case
$14.16
+552.5%
Avg target
Bull Case
$18.59
+756.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.99
-56.5% from high
52-Week Low
$0.56
+290.1% from low
Target vs 52W High
$14.16
+183.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%